Inhibitory and bactericidal potential of crude acetone extracts of combretum molle (Combretaceae) on drug-resistant strains of Helicobacter pylori

Journal of Health, Population and Nutrition

Volumn 29, Issue 5, 2011, Pages 438-445

  Njume, Collise ^a   Afolayan, Anthony J ^a   Samie, Amidou ^b   Ndip, Roland N ^a,c  

^a UNIVERSITY OF FORT HARE   (South Africa)

^b UNIVERSITY OF VENDA   (South Africa)

^c UNIVERSITY OF BUEA   (Cameroon)

Author keywords

Acetone; Antibiotic resistance; Combretum molle; Crude extracts; Helicobacter pylori; Microbial sensitivity tests; Minimum inhibitory concentration; South Africa

Indexed keywords

ACETONE; ANTIINFECTIVE AGENT; ANTIULCER AGENT; PLANT EXTRACT; SOLVENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BARK; CHEMISTRY; COMBRETUM; COMPARATIVE STUDY; DRUG EFFECT; HELICOBACTER PYLORI; PLANT STEM;

ACETONE; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; COMBRETUM; DRUG RESISTANCE, BACTERIAL; HELICOBACTER PYLORI; PLANT BARK; PLANT EXTRACTS; PLANT STEMS; SOLVENTS;

EID: 83455210136     PISSN: 16060997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ndip RN, Malange TAE, Ojongokpoko JEA, Luma HN, Malongue A, Akoachere JFK et al. Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram. Trop Med Inter Health 2008;13:848-54.
2. Adeniyi CB, Lawal TO, Mahady GB. In vitro susceptibility of Helicobacter pylori to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana. Pharmaceut Biol 2009;47:99-102.
3. Romano M, Cuomo A. Eradication of Helicobacter pylori: a clinical update. Med Gen Med 2004;6:19.
4. Tanih NF, Okeleye BI, Naidoo N, Clarke AM, Mkwetshana N, Green E et al. Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implication. S Afr Med J 2010; 100:49-52.
5. Njume C, Afolayan AJ, Ndip RN. An overview of antimicrobial resistance and the future of medicinal plants in the treatment of Helicobacter pylori infections. Afr J Pharm Pharmacol 2009;3:685-99.
6. Lai CH, Kuo CH, Chen PY, Poon SK, Chang CS, Wang WC. Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates. J Antimicrob Chemother 2006;57:466-71.
7. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
8. Eisig JN, Silva FM, Barbuti RC, Rodriguez TN, Malfertheiner P, Moraes Filho JP et al. Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication. BMC Gastroenterol 2009;9:38.
9. Aboderin OA, Abdu AR, Odetoyin B, Okeke IN, Lawal O O, Ndububa DA et al. Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-West, Nigeria. Afr Health Sci 2007;7:143-7.
10. Me'Graud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007;20:280-322.
11. Tanih NF, McMillan M, Naidoo N, Ndip LM, Weaver LT, Ndip RN. Prevalence of Helicobacter pylori VacA, CagA and iceA genotypes in South African patients with upper gastrointestinal diseases. Acta tropica 2010; 116:68-73.
12. Bohr UR, Malfertheiner P. Eradication of H. pylori infection: the challenge is on if standard therapy fails. Therapeut Advan Gastroenterol 2009;2:59-66.
13. Samie A, Obi CL, Bessong PO, Namrita L. Activity profiles of fourteen selected medicinal plants from rural Venda communities in South Africa against fifteen clinical bacterial species. Afr J Biotechnol 2005; 4:1443-51.
14. Ndip RN, Malange Tarkang AE, Mbullah SM, Luma HN, Malongue A, Ndip LM et al. In vitro anti-Helicobacter pylori activity of extracts of selected medicinal plants from North West Cameroon. J Ethnophamacol 2007;114:452-7.
15. Eloff JN, Katerere DR, Mcgaw LJ. The biological activity and chemistry of the southern African Combretaceae. J Ethnopharmacol 2008;119:686-99.
16. Elegami AA, Osman SM, Omer ME, Ishag KM. In-vitroantibacterial activity of some Sudanese Combretum species. Inter J Trop Med 2007;2:45-51.
17. Samie A, Obi CL, Barrett LJ, Powell SM, Guerrant RL. Prevalence of Campylobacter species, Helicobacter pylori and Arcobacter species in stool samples from the Venda region, Limpopo, South Africa: studies using molecular diagnostic methods. J Infect Dis 2007;54:558-66.
18. Dube C, Nkosi TC, Clarke AM, Mkwetshana N, Green E, Ndip RN. Helicobacter pylori antigenemia in an asymptomatic population of the Eastern Cape province, South Africa: public health implications. Rev Environ Health 2009;24:249-55.
19. Castillo-Juárez I, González V, Aime-Aguilar H, Martínez G, Linares E, Bye R et al. Anti-Helicobacter pylori activity of plants used in Mexican traditional medicine for gastrointestinal disorders. J Ethnopharmacol 2009;122:402-5.
20. Boyanova L, Gergova G, Nikolov R, Derejian S, Lazarova E, Katsarov N et al. Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods. J Med Microbiol 2005;54:481-3.
21. Bonacorsi C, Raddi MS, Carlos IZ, Sannomiya M, Vilegas W. Anti-Helicobacter pylori activity and immunostimulatory effect of extracts from Byrsonima crassa Nied. BMC Complement Alternat Med 2009;9:2.
22. Akinpelu DA, Aiyegoro AO, Okoh AI. Studies on the biocidal and cell membrane disruption potentials of stem bark extracts of Afzelia africana (Smith). Biol Res 2009;42:339-49.
23. Graham D, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59:1143-53.
24. Smith SI, Oyedeji KS, Arigbabu AO, Atimomo C, Coker AO. High amoxicillin resistance in Helicobacter pylori isolated from gastritis and peptic ulcer patients in Western Nigeria. J Gastroenterol 2001;36:67-8.
25. Masoko P, Picard J, Eloff JN. The antifungal activity of twenty-four Southern African Combretum species (Combretaceae). S Afr J Bot 2007;73:173-83.
26. Fyhrquist P, Mwasumbi L, Hæggström CA, Vuorela H, Hiltunen R, Vuorela P. Ethnobotanical and antimicrobial investigation on some species of Terminalia and Combretum (Combretaceae) growing in Tanzania. J Ethnopharmacol 2002;79:169-77.
27. Ezekiel CN, Anokwuru CP, Nsofor E, Odusanya OA, Adebanjo O. Antimicrobial activity of the methanolic and crude alkaloid extracts of Acalypha wilkesiana cv. macafeeana copper leaf. Res J Microbiol 2009;4:269-77.
28. Nunes PH, Cavalcanti PM, Galvão SM, Martins MC. Antiulcerogenic activity of Combretum leprosum. Pharmazie 2009;64:58-62.
29. Eloff JN. Which extractant should be used for the screening and isolation of antimicrobial components from plants? J Ethnopharmacol 1998;60:1-8.
30. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev 1999;12:564-82.
31. Afolayan AJ, Lewu FB. Antimicrobial activity of Alepidea amatymbica. Pharmaceut Biol 2009;47:436-9.
32. Hernández NE, Tereschuk ML, Abdala LR. Antimicrobial activity of flavonoids in medicinal plants from Tafí del Valle (Tucumán, Argentina). J Ethnopharmacol 2000;73:317-22.
33. Schinor EC, Salvador MJ, Ito IY, Dias DA. Evaluation of the antimicrobial activity of crude extracts and isolated constituents from Chresta scapigera. Brazil J Microbiol 2007;38:145-9.
34. Onocha PA, Audu EO, Ekundayo O, Dosumu OO. Phytochemical and antimicrobial properties of extracts of Combretum racemosum. Acta Hort 2005;675:97-101.
35. Eloff JN, Famakin JO, Katerere DRP. Combretum woodii (Combretaceae) leaf extracts have high activity against gram-negative and gram-positive bacteria. Afr J Biotechnol 2005;4:1161-6.